Nurse Practitioner, Family · Tyler, TX
NPI
1316950603
Since 2006
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1720 South Beckham
Tyler, TX, 75701
Phone (903) 595-5101
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
501 services
Medicare patients, 2024
279
Average age 74
Drug cost, 2024
$4.8M
3,449 prescriptions
Company payments, 2025
$41K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Machelle A McDowell was code 99214 (office e&m - established), 349 times for 232 patients. In total Machelle A McDowell billed 501 services in 16 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 349 | 232 | $56.77 | $20K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 47 | 33 | $10.38 | $488 |
| 99443 Telephone Services | Facility | 28 | 25 | $56.58 | $1,584 |
| 99213 Office E&M - Established | Facility | 21 | 21 | $33.78 | $709 |
| 36415 Venipuncture Blood Collection | Office | 19 | 12 | $8.65 | $164 |
| 99442 Telephone Services | Facility | 13 | 13 | $30.50 | $396 |
By year: 2022 $41K for 807 services; 2023 $26K for 482 services; 2024 $24K for 501 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 19 | 12 | $8.65 | $164 |
Medicare prescription drug claims, 2024
In 2024, the drug Machelle A McDowell prescribed most often to Medicare patients was Pantoprazole Sodium, with 362 prescriptions and refills. In total Machelle A McDowell wrote 3,449 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 362 | 831 | 109 | $4,757 |
| Omeprazole Generic | 328 | 745 | 90 | $5,454 |
| Dicyclomine Hcl Generic | 186 | 288 | 58 | $6,037 |
| Linzess Linaclotide | 129 | 213 | 28 | $113K |
| Xifaxan Rifaximin | 113 | 115 | 27 | $346K |
| Stelara Ustekinumab | 108 | 198 | 20 | $2.8M |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 106 | 115 | 37 | $5,379 |
| Creon Lipase/Protease/Amylase | 104 | 139 | 19 | $311K |
| Mesalamine Generic | 103 | 165 | 24 | $41K |
| Promethazine Hcl Generic | 89 | 89 | 19 | $1,098 |
| Ondansetron Hcl Generic | 88 | 92 | 29 | $971 |
| Colestipol Hcl Generic | 86 | 199 | 31 | $16K |
| Loperamide Loperamide Hcl | 84 | 98 | 27 | $3,224 |
| Famotidine Generic | 83 | 174 | 20 | $1,505 |
| Esomeprazole Magnesium Generic | 80 | 161 | 21 | $2,498 |
Brand drugs: - claims; generic drugs: 2,631 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Machelle A McDowell $41K ($40K in general payments such as food, travel and fees and $1,190 for research) from 16 companies. The largest payer was Janssen Biotech, Inc. with $32K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 49 | $32K |
| Abbvie Inc. ABBV | 76 | $7,072 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 16 | $381 |
| Genzyme Corporation SNY | 7 | $324 |
| Janssen Scientific Affairs, LLC JNJ | 3 | $310 |
| Ardelyx, Inc. ARDX | 3 | $160 |
| Aimmune Therapeutics, Inc. | 2 | $138 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $73.58 |
| Janssen Research & Development, LLC JNJ | 1 | $53.8 |
| Lilly USA, LLC LLY | 3 | $52.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.